Future Oncology Journal Issues Research Articles in Part 2 of June 2020 Edition
June 02, 2020
June 02, 2020
LONDON, England, June 2 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles, including the following topics, in Part 2 of its June 2020 edition:
* Cost-effectiveness analysis of nivolumab in the second-line treatment for advanced esophageal squamous cell carcinoma
* Angiogenic and immunomodulatory biomarkers in axitinib-treated patients with advanced renal cell carcinoma
Review:
. . .
* Cost-effectiveness analysis of nivolumab in the second-line treatment for advanced esophageal squamous cell carcinoma
* Angiogenic and immunomodulatory biomarkers in axitinib-treated patients with advanced renal cell carcinoma
Review:
. . .